<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR114">
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Khanal</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Barras</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Vausselin</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Feneant</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Boukherroub</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Siriwardena</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Dubuisson</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Szunerits</surname>
    <given-names>S</given-names>
   </name>
  </person-group>
  <article-title>Boronic acid-modified lipid nanocapsules: a novel platform for the highly efficient inhibition of hepatitis C viral entry</article-title>
  <source>Nanoscale</source>
  <year>2015</year>
  <volume>7</volume>
  <fpage>1392</fpage>
  <lpage>1402</lpage>
  <pub-id pub-id-type="doi">10.1039/C4NR03875D</pub-id>
  <?supplied-pmid 25502878?>
  <pub-id pub-id-type="pmid">25502878</pub-id>
 </element-citation>
</ref>
